<DOC>
	<DOCNO>NCT00580086</DOCNO>
	<brief_summary>This study do evaluate MR spectroscopy give u information whether chemotherapy work . Spectroscopy special set picture take Magnetic Resonance Imaging ( MRI ) give u information chemical composition breast cancer .</brief_summary>
	<brief_title>Monitoring Response Neoadjuvant Chemotherapy Use Breast Proton MR Spectroscopy</brief_title>
	<detailed_description>The study aim perform MR Spectroscopy ( 1H MRS ) 1.5 Tesla ( 1.5T ) , use software package General Electric Medical Systems , Milwaukee , WI 115 patient biopsy proven adenocarcinoma breast , receive neoadjuvant chemotherapy per standard therapeutic protocol , prior surgical management . The spectroscopic data analyze determine whether enable early prediction therapeutic response assess RECIST ultimately surgical pathology completion full course drug treatment . The 1H MRS , perform baseline , prior treatment , halfway end chemotherapy course , prior surgery , add routine MRI examination affect breast . Since chemotherapy course vary length , exact timeline depend specific course give . 1H MRS add 10 minute routine MRI examination , involve additional injection contrast . In addition , perform two extra MRIs combine 1H MRS examination affect breast , one set day second set one week initiation chemotherapy . The MRI 1H MRS perform Memorial Sloan-Kettering Cancer Center , 1275 York Avenue , NY , NY 10021 offsite MSKCC .</detailed_description>
	<criteria>Patients need â‰¥ 18 year age Patients biopsy confirm adenocarcinoma breast , schedule receive neoadjuvant chemotherapy prior surgical management . Patients would normally exclude undergo MRI examination include : Patients pacemaker , aneurysm clip condition would warrant avoidance strong magnetic field Patients pregnant Patients unable comply complete MRI exam patient claustrophobia patient electrically , magnetically , mechanically activated implant , heart pacemaker , certain type artificial joint , inner ear implant , eye implant , certain surgical clip use vascular surgery . Patients candidate neoadjuvant chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>MR spectroscopy</keyword>
	<keyword>Neoadjuvant chemotherapy</keyword>
</DOC>